Previous 10 | Next 10 |
CONMED Corporation (CNMD) Q3 2022 Earnings Conference Call October 26, 2022 04:30 p.m. ET Company Representatives Curt Hartman - Chair of the Board, President, Chief Executive Officer Todd Garner - Executive Vice President, Chief Financial Officer Conference Ca...
The following slide deck was published by CONMED Corporation in conjunction with their 2022 Q3 earnings call. For further details see: CONMED Corporation 2022 Q3 - Results - Earnings Call Presentation
CONMED press release ( NYSE: CNMD ): Q3 Non-GAAP EPS of $0.77 beats by $0.02 . Revenue of $275.09M (+10.6% Y/Y) misses by $5.8M . Shares -4.1% . The Company is narrowing its revenue guidance for the full year 2022 and now expects revenue between $1.1 bi...
CONMED Corporation (NYSE: CNMD) today announced financial results for the third quarter ended September 30, 2022. Third Quarter 2022 Highlights Sales of $275.1 million increased 10.6% year over year as reported and 12.1% in constant currency. Acquisitions contributed a...
Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This report optimizes tradi...
CONMED Corporation (NYSE: CNMD) today announced that it will report financial results for the third quarter 2022 after the market close on Wednesday, October 26, 2022. The Company’s management will host a conference call at 4:30 p.m. ET that same day to discuss the results. T...
Summary CONMED continues to attract sellers this week as equity markets continue digesting the latest macroeconomic data. Whilst unprofitable medtech has shone in recent years, it's failed to catch a bid in the July bounce, leaving names like CNMD behind. Quarterly operating p...
CONMED Corporation (NYSE: CNMD) today announced that Curt R. Hartman, Chair of the Board, President, and Chief Executive Officer, and Todd W. Garner, Executive Vice President and Chief Financial Officer, will participate in a fireside chat at the 20 th Annual Morgan Stanley Glob...
Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This report optimizes tradi...
CONMED Corporation (NYSE: CNMD) today announced that it has completed its previously announced acquisition of privately-held Biorez, Inc. Biorez is a medical device start-up based in New Haven, CT and is focused on advancing the healing of soft tissue using its proprietary BioBr...
News, Short Squeeze, Breakout and More Instantly...
Conmed Corp. - Ordinary Shares Company Name:
CNMD Stock Symbol:
NASDAQ Market:
Conmed Corp. - Ordinary Shares Website:
2024-07-18 18:42:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
CONMED Corporation (NYSE: CNMD) today announced it will report financial results for the second quarter of 2024 after the market close on Wednesday, July 31, 2024. The Company’s management will host a conference call at 4:30 p.m. ET that same day to discuss the results. To participat...
2024-07-08 16:16:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...